Drawing for SYMPLEITOPE

USPTO serial 87745494

SYMPLEITOPE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
AYALA, LOURDES
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SYMPLEITOPE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Philip R. Zender, Esq.

PHILIP R. ZENDER, ESQ. SQUIRE PATTON BOGGS (US) LLP275 BATTERY STREET, SUITE 2600SAN FRANCISCO, CA 94111UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biological preparations, namely, Antigen-binding molecules for scientific and research purposesACTIVE—
005Biological Antigen-binding molecules for medical purposes for human medical diagnostics and analysis; Biological therapeutic preparations for the prevention and treatment of cancer, inflammatory diseases, and transplant rejectionACTIVE—
042Custom selection, design, and development of antigen-binding molecules for scientific, research, human medical diagnostics and analysis purposes and antigen-binding molecule therapeutic preparations for the prevention and treatment of cancer, inflammatory diseases, and transplant rejectionACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 9, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 9, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 31, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 29, 2019EX1GSOU EXTENSION 1 GRANTED—
Jul 29, 2019EXT1SOU EXTENSION 1 FILED—
Jul 29, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 5, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 11, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 11, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 21, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 2, 2018ALIEASSIGNED TO LIE—
Oct 18, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 17, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Oct 17, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 17, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 17, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 19, 2018GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 19, 2018GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 19, 2018CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 16, 2018DOCKASSIGNED TO EXAMINER—
Jan 19, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 9, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance